Literature DB >> 9826396

Enteropathogenic Escherichia coli virulence genes encoding secreted signalling proteins are essential for modulation of Caco-2 cell electrolyte transport.

G K Collington1, I W Booth, M S Donnenberg, J B Kaper, S Knutton.   

Abstract

The pathophysiology of enteropathogenic Escherichia coli (EPEC) diarrhea remains uncertain. In vitro, EPEC stimulates a rapid increase in short-circuit current (Isc) across Caco-2 cell monolayers coincident with intimate attaching and effacing (A/E) bacterial adhesion. This study has examined the roles of specific EPEC virulence proteins in this Isc response. EPEC genes encoding EspA, EspB, and EspD, essential for signal transduction in host cells and A/E activity, were also required for modulation of Caco-2 electrolyte transport.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826396      PMCID: PMC108772     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid.

Authors:  A E Jerse; J B Kaper
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector.

Authors:  M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

3.  A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells.

Authors:  M S Donnenberg; J Yu; J B Kaper
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

4.  Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers.

Authors:  C Canil; I Rosenshine; S Ruschkowski; M S Donnenberg; J B Kaper; B B Finlay
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

5.  Signal transduction in human epithelial cells infected with attaching and effacing Escherichia coli in vitro.

Authors:  M Dytoc; L Fedorko; P M Sherman
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

6.  Examination of enteropathogenic Escherichia coli strains for an adenylcyclase stimulating factor.

Authors:  D Law; K M Wilkie; R Freeman
Journal:  J Med Microbiol       Date:  1987-06       Impact factor: 2.472

7.  Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.

Authors:  M S Donnenberg; C O Tacket; S P James; G Losonsky; J P Nataro; S S Wasserman; J B Kaper; M M Levine
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S Knutton; T Baldwin; P H Williams; A S McNeish
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

9.  Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake.

Authors:  I Rosenshine; M S Donnenberg; J B Kaper; B B Finlay
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

10.  A diarrheal pathogen, enteropathogenic Escherichia coli (EPEC), triggers a flux of inositol phosphates in infected epithelial cells.

Authors:  V Foubister; I Rosenshine; B B Finlay
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Virulence of enteropathogenic Escherichia coli, a global pathogen.

Authors:  S C Clarke; R D Haigh; P P E Freestone; P H Williams
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 2.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.

Authors:  Jennifer Lising Roxas; Katheryn Ryan; Gayatri Vedantam; V K Viswanathan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-06-05       Impact factor: 4.052

Review 4.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 5.  Exploitation of host cells by enteropathogenic Escherichia coli.

Authors:  B A Vallance; B B Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  Role of EspB in experimental human enteropathogenic Escherichia coli infection.

Authors:  C O Tacket; M B Sztein; G Losonsky; A Abe; B B Finlay; B P McNamara; G T Fantry; S P James; J P Nataro; M M Levine; M S Donnenberg
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 8.  Pathogenicity islands in bacterial pathogenesis.

Authors:  Herbert Schmidt; Michael Hensel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Competition of Lactobacillus paracasei with Salmonella enterica for adhesion to Caco-2 cells.

Authors:  Alicja Jankowska; Daniel Laubitz; Hanna Antushevich; Romuald Zabielski; Elzbieta Grzesiuk
Journal:  J Biomed Biotechnol       Date:  2008

10.  EspT triggers formation of lamellipodia and membrane ruffles through activation of Rac-1 and Cdc42.

Authors:  Richard R Bulgin; Ana Arbeloa; Jade C S Chung; Gad Frankel
Journal:  Cell Microbiol       Date:  2008-10-30       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.